tiprankstipranks
Trending News
More News >
Abbott Laboratories (ABT)
NYSE:ABT
US Market
Advertisement

Abbott Laboratories (ABT) Earnings Dates, Call Summary & Reports

Compare
8,777 Followers

Earnings Data

Report Date
Jan 28, 2026
Before Open (Confirmed)
Period Ending
2025 (Q4)
Consensus EPS Forecast
1.5
Last Year’s EPS
1.34
Same Quarter Last Year
Based on 19 Analysts Ratings

Earnings Call Summary

Q3 2025
Earnings Call Date:Oct 15, 2025|
% Change Since:
|
Earnings Call Sentiment|Positive
The earnings call reflects a generally positive performance with strong growth in most segments, particularly in medical devices and international markets. However, challenges remain, particularly in the diagnostics market in China and impacts from tariffs.
Company Guidance
During Abbott Laboratories' Third Quarter 2025 Earnings Conference Call, the company reported a 7.5% organic sales growth, excluding COVID test sales, driven by double-digit growth in medical devices and high single-digit growth in established pharmaceuticals. Earnings per share rose to $1.30, representing a high single-digit increase compared to the previous year. New product launches contributed nearly $5 billion in sales, adding over 100 basis points to organic sales growth. In Nutrition, sales increased by 4%, while Core Lab Diagnostics saw a 7% growth outside of China. Medical Devices grew by 12.5%, with diabetes care, electrophysiology, and cardiac rhythm management leading the growth. The adjusted gross margin was 55.8% of sales, with an adjusted operating margin of 23%. Abbott Laboratories remains on track to deliver high single-digit organic sales growth and double-digit EPS growth, with continued investment in product innovation and market expansion.
Strong Organic Sales Growth
Reported organic sales growth of 7.5%, excluding COVID test sales. Growth was led by double-digit growth in medical devices and high single-digit growth in established pharmaceuticals.
Earnings Per Share Increase
Earnings per share rose to $1.30, up high single digits compared to last year and up double digits excluding the expected decline in COVID test sales.
Nutrition Segment Growth
Sales in the Nutrition segment increased by 4%, driven by 10% growth in international markets for adult nutrition products like Ensure and Glucerna.
Medical Devices Surge
Medical Devices sales grew 12.5%, with significant growth in diabetes care, electrophysiology, and cardiac rhythm management.
Strong Performance Outside China
Core Lab Diagnostics grew 7% outside of China, with markets such as the US showing an acceleration in growth.

Abbott Laboratories (ABT) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

ABT Earnings History

Report Date
Fiscal Quarter
Forecast / EPS
Last Year's EPS
EPS YoY Change
Press Release
Slides
Play Transcript
Jan 28, 2026
2025 (Q4)
1.50 / -
1.34
Oct 15, 2025
2025 (Q3)
1.30 / 1.30
1.217.44% (+0.09)
Jul 17, 2025
2025 (Q2)
1.26 / 1.26
1.1410.53% (+0.12)
Apr 16, 2025
2025 (Q1)
1.07 / 1.09
0.9811.22% (+0.11)
Jan 22, 2025
2024 (Q4)
1.34 / 1.34
1.1912.61% (+0.15)
Oct 16, 2024
2024 (Q3)
1.20 / 1.21
1.146.14% (+0.07)
Jul 18, 2024
2024 (Q2)
1.10 / 1.14
1.085.56% (+0.06)
Apr 17, 2024
2024 (Q1)
0.95 / 0.98
1.03-4.85% (-0.05)
Jan 24, 2024
2023 (Q4)
1.19 / 1.19
1.0315.53% (+0.16)
Oct 18, 2023
2023 (Q3)
1.10 / 1.14
1.15-0.87% (-0.01)
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed

ABT Earnings-Related Price Changes

Report Date
Price 1 Day Before
Price 1 Day After
Percentage Change
Oct 15, 2025
$132.68$129.45-2.43%
Jul 17, 2025
$131.16$119.98-8.52%
Apr 16, 2025
$125.10$128.55+2.76%
Jan 22, 2025
$115.22$116.20+0.85%
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.

FAQ

When does Abbott Laboratories (ABT) report earnings?
Abbott Laboratories (ABT) is schdueled to report earning on Jan 28, 2026, Before Open (Confirmed).
    What is Abbott Laboratories (ABT) earnings time?
    Abbott Laboratories (ABT) earnings time is at Jan 28, 2026, Before Open (Confirmed).
      Where can I see when companies are reporting earnings?
      You can see which companies are reporting today on our designated earnings calendar.
        What companies are reporting earnings today?
        You can see a list of the companies which are reporting today on TipRanks earnings calendar.
          What is ABT EPS forecast?
          ABT EPS forecast for the fiscal quarter 2025 (Q4) is 1.5.

            Abbott Laboratories (ABT) Earnings News

            ABT Earnings: Abbott Laboratories Stock Slips on Mixed Q1 Results
            Premium
            Market News
            ABT Earnings: Abbott Laboratories Stock Slips on Mixed Q1 Results
            6M ago
            ABT Earnings: Abbott Posts Mixed Q4 Results, Issues FY25 Growth Outlook
            Premium
            Market News
            ABT Earnings: Abbott Posts Mixed Q4 Results, Issues FY25 Growth Outlook
            9M ago
            ABT Earnings: Strong Medical Device Sales Help Abbott Beat Q3 Estimates
            Premium
            Market News
            ABT Earnings: Strong Medical Device Sales Help Abbott Beat Q3 Estimates
            1y ago
            ABT Earnings: Abbott’s Q3 Earnings Top Street Expectations
            Premium
            Market News
            ABT Earnings: Abbott’s Q3 Earnings Top Street Expectations
            1y ago
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis